Assistant Professor of Medicine
Director of Education and Training
Rheumatology Director, Yale Lupus Program
Yale School of Medicine
Systemic Lupus Erythematosus Treatment Advances: Anifrolumab
The rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.
2 Commerce Drive Cranbury, NJ 08512